Showing results (201-210 of 405) with videos related to
Sort By:
Pageof 41
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
Phenome-wide examination of comorbidity burden and multiple sclerosis disease severityTingting Zhang, Matthew Goodman, Feng Zhu, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 12, 2018
Fatty acid binding protein-4 is associated with disability in multiple sclerosis patientsRiley Bove, Brain C Healy, Alexander Musallam, et al.Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
GWAS highlights the neuronal contribution to multiple sclerosis susceptibilityLu Zeng, Khan Atlas, Tsering Lama, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2019
Microstructural fronto-striatal and temporo-insular alterations are associated with fatigue in patients with multiple sclerosis independent of white matter lesion load and depressionMiklos Palotai, Michele Cavallari, Ismail Koubiyr, et al.NPJ Digital Medicine|October 21, 2020
Ensemble learning predicts multiple sclerosis disease course in the SUMMIT studyYijun Zhao, Tong Wang, Riley Bove, et al.Proteomics. Clinical Applications|February 27, 2023
Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosisFerhan Qureshi, Wayne Hu, Louisa Loh, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2024
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated diseasePhilippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, et al.Pediatrics|June 1, 2017
Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple SclerosisJennifer S Graves, Tanuja Chitnis, Bianca Weinstock-Guttman, et al.Journal of Neuroimmunology|December 1, 2010
Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatmentsRobert Gross, Brian C Healy, Sabine Cepok, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 27, 2022
Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?Trishna Bharadia, Jo Vandercappellen, Tanuja Chitnis, et al.Pageof 41